BU-NOT-SET

CONTACT US
Ensuring stability excellence for global consumer and OTC products
  • Analytical chemistry
  • Drug product
Woman and computer
Webinar
The impact of the COVID-19 pandemic on global pharmaceutical growth
  • Industry trends
Eyes
Insight
COVID-19: a year of unprecedented change
  • Industry trends
Eyes
Insight
Oral solids: market and technology trends
  • Drug product
Eyes
Insight
Oral modified release
  • Drug product
Granules
Fact sheet
Semi-solids an overview of current regulatory requirement
  • Drug product
Tube cream
Fact sheet
API relocation strategies for CDMO’s
  • Drug substance
Eyes
Insight
Clinical trial material
  • Drug product
  • Manufacturing
hand scooping pills
Fact sheet
Time and cost-effective solubility improvement
  • Drug substance
Eyes
Insight
Case study
  • Drug product
Modified release fixed dose combination product with two poorly soluble drug substances
Insight
  • Drug product
Patient centricity during drug development and commercialisation
Insight
  • Drug product
10 considerations to kick-start your drug development journey
Insight
  • Drug product
Guidance for start-ups on drug development
White paper
  • Drug product
  • Drug substance
Drug development for start-ups
Insight
  • Sustainability
Optimising environmental sustainability
Insight
  • Industry trends
Adapting to deal with the COVID-19 pandemic
Insight
  • Sustainability
On Drug Delivery – Sustainability Q&A
Insight
  • Analytical chemistry
Optimising analytical chemistry to improve speed to market